Related Experiment Video
Updated: Jun 20, 2025

04:04
Electroacupuncture Combined with Chinese Medicine Ironing Therapy for Functional Constipation
Published on: July 5, 2024
381
Electroacupuncture for lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for a
Lili Zhu1, Yan Yan1, Jinna Yu1
1Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
BMJ Open
|July 20, 2024
Summary
This study investigates electroacupuncture (EA) for benign prostatic hyperplasia (BPH) and its associated lower urinary tract symptoms (LUTS). Researchers aim to determine if EA is a safe and effective treatment for improving LUTS in men with BPH.
Area of Science:
- Urology
- Integrative and Complementary Medicine
- Clinical Trials
Background:
- Benign prostatic hyperplasia (BPH) is a prevalent condition in men over 40, causing lower urinary tract symptoms (LUTS) that impair quality of life.
- Acupuncture, specifically electroacupuncture (EA), is being explored as a potential therapeutic option for BPH-related LUTS, but its efficacy requires rigorous evaluation.
- Current treatment options for BPH and LUTS may have limitations or side effects, driving the need for alternative therapies like EA.
Purpose of the Study:
- To evaluate the efficacy and safety of electroacupuncture (EA) in alleviating lower urinary tract symptoms (LUTS) in men diagnosed with benign prostatic hyperplasia (BPH).
- To compare the effects of EA against sham electroacupuncture (SA) in a multicentre, randomized, controlled trial setting.
- To assess the impact of EA on the International Prostate Symptom Score (IPSS) over an 8-week treatment period and a subsequent 24-week follow-up.
Main Methods:
- A two-arm, sham-controlled, subject- and assessor-blinded randomized trial involving 306 male patients aged 40-80 with moderate to severe LUTS due to BPH.
- Participants will receive either EA or SA for 24 sessions over 8 weeks, followed by a 24-week follow-up period.
- The primary outcome measure is the proportion of participants achieving at least a 30% reduction in their total IPSS from baseline at weeks 8 and 20. Intention-to-treat analysis will be employed.
Main Results:
- Primary outcome data regarding the reduction in International Prostate Symptom Score (IPSS) at weeks 8 and 20 are being collected.
- Safety data on adverse events associated with electroacupuncture (EA) and sham electroacupuncture (SA) will be analyzed.
- Statistical significance will be determined using a two-tailed p-value less than 0.05.
Conclusions:
- The study is designed to provide robust evidence on the effectiveness and safety of electroacupuncture (EA) for benign prostatic hyperplasia (BPH).
- Findings are anticipated to inform clinical practice regarding the use of EA as a treatment for lower urinary tract symptoms (LUTS).
- Results will be disseminated through publication in a peer-reviewed journal.

